Becton, Dickinson and Company BDX, popularly known as BD, announced that the FDA granted 510(k) clearance for its novel blood collection device, MiniDraw. This revolutionary device is likely to ...

BD MiniDraw™ Capillary Blood Collection System Enables Lab-Quality Blood Testing from Less Invasive Method than Venous Collection in More Convenient Locations FRANKLIN LAKES, N.J., Dec. 7, 2023 ...

BD’s new MiniDraw diagnostic devices could let pharmacists—and, one day, maybe patients—manage blood testing needs and monitor health conditions. BD received its FDA authorizations for two blood draw ...

The BD P800™ Blood Collection System stands at the forefront of metabolic research, particularly in the context of obesity. Its unique ability to stabilize critical plasma markers has revolutionized ...

Credit: Becton, Dickinson and Company. The system consists of a capillary blood collection tube and a finger sleeve that is intended for use by a trained health care provider, without the need of a ...

Longtime partners in simplifying blood sample collection and testing, BD and Babson Diagnostics are now making their miniaturized approach available to healthcare providers after years of development.

BD is building on its goal of providing patients with a “one-stick hospital stay” with a new FDA clearance for painless blood collection hardware that works through already placed IV lines. The ...

Not-for-profit healthcare organisation Carilion Clinic is set to provide needle-free blood draws to patients leveraging Becton, Dickinson and Company’s (BD) blood collection device. This initiative to ...

BD (Becton, Dickinson and Co.) announced on July 20 that through its recent acquisition of Velano Vascular it has taken a step forward in transforming the patient experience through a vision of a “One ...

Please provide your email address to receive an email when new articles are posted on . The BD MiniDraw device is part of a blood testing collection system that is designed to make routine blood tests ...

(RTTNews) - Medical technology company Becton, Dickinson and Co. or BD (BDX) announced Thursday it has received 510(k) clearances from the U.S. Federal Drug Administration (FDA) for a novel blood ...